NCT04044898View on ClinicalTrials.gov

Pharmacokinetics and Safety of ALA in Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

December 6, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

ALA 5%

prepare 5% ALA solution, apply topically to the affected area for 1.5 hours, single dose

DRUG

ALA 10%

prepare 10% ALA solution, apply topically to the affected area for 3 hours, single dose

Trial Locations (1)

200040

Huashan Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT04044898 - Pharmacokinetics and Safety of ALA in Acne Vulgaris | Biotech Hunter | Biotech Hunter